IPP Bureau
USFDA inspection: Zydus Lifesciences and Gland Pharma
By IPP Bureau - January 28, 2023
The United States Food and Drug Administration (USFDA) conducted an inspection at Gland Pharma Limited API Facility at JNPC, Visakhapatnam
Dr. Reddy's Laboratories launches Difluprednate Ophthalmic Emulsion 0.05% in US
By IPP Bureau - January 28, 2023
The Durezol brand and generic had US sales of approximately US $40 million MAT for the most recent twelve months ending in Nov 2022 according to IQVIA
USFDA provides exception to Glenmark's Baddi facility
By IPP Bureau - January 28, 2023
The company will engage with the agency to resolve the import alert at the earliest.
Bliss GVS Pharma posts Q3 FY23 consolidated PAT at Rs. 27.94 Cr
By IPP Bureau - January 28, 2023
The company has reported total income of Rs. 211.36 crores during the period ended December 31, 2022
Pharma companies developing vaccines with efficacy against Omicron variants will gain competitive advantage in China, says GlobalData
By IPP Bureau - January 27, 2023
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
Biocon Foundation bags 'IHW Gold Award for Diseases Screening Initiative of the Year' for 2022
By IPP Bureau - January 27, 2023
Biocon Foundation has pioneered a mHealth-technology-based (mobile health) oral cancer screening program in India
Sun Pharma launches SEZABY in the US for treatment of neonatal seizures
By IPP Bureau - January 27, 2023
SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection
Dr. Reddys Laboratories Q3 FY2023 consolidated PAT up to Rs. 1243.9 Cr
By IPP Bureau - January 27, 2023
The company has reported total income of Rs. 6848.5 crores during the period ended December 31, 2022
Torrent Pharmaceuticals posts Q3FY23 consolidated PAT at Rs. 283 Cr
By IPP Bureau - January 27, 2023
The company has reported total income of Rs. 2481 crores during the period ended December 31, 2022
Thermo Fisher launches big foot cell sorter in India
By IPP Bureau - January 25, 2023
Cell sorting technology supports researchers advancing new therapies
CrisprBits develops CRISPR-based SARS-CoV2 test OmiCrisp
By IPP Bureau - January 25, 2023
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
Granules Pharmaceuticals receives ANDA approval for amphetamine mixed salts ER capsules
By IPP Bureau - January 25, 2023
Granules now have a total of 53 ANDA approvals from USFDA
Fadnavis inaugurates 310-bed Medicover Hospitals in Navi Mumbai
By IPP Bureau - January 25, 2023
Medical Tourism will boost India’s economy
75% of asthma patients have worse symptoms during cold or flu
By IPP Bureau - January 25, 2023
Asthma patients are more likely to have an asthma attack during winter
USFDA inspection at Indoco Remedies's Solid Oral Formulation Facility at Goa
By IPP Bureau - January 24, 2023
USFDA issued issued Form 483 with nine observations, which will be addressed within stipulated time.
